Cart
0
Get 20% Free Customization In This Report
Buy this report from - $4176

In Vitro Fertilization (IVF) Services Market by Cycle Type (Fresh, Thawed IVF and Donor Egg IVF Cycle) and End User (Fertility Clinics, Hospitals, Surgical Centres and Clinical Research Institutes) - Global Opportunity Analysis and Industry Forecast, 2017-2023

LI_17678
Pages: 568
Dec 2017 | 4927 Views
face gplus_n
Author's : Abha Thakur and Onkar Sumant
Tables: 238
Charts: 174
twit_n pr_n

In Vitro Fertilization (IVF) Services Market Overview:

In Vitro Fertilization (IVF) Services Market generated a revenue of $9,876 million in 2016 and is expected to reach $19.676 million by 2023, at a CAGR of 10.5% from 2017 to 2023. In vitro fertilization is the process of artificial fertilization used to treat infertility or genetic problems globally. It is the most efficient assisted reproductive technology (ART), helping couples or single parents around the world. However, IVF does not always give successful results and its success rate varies from individual to individual. It has emerged as a preferable choice for fertility treatments in the clinical industry. Approximately, 1.5% of babies born in the U.S. are through ART. This procedure is performed in a clinical laboratory where the matured egg (self-egg or donor’s egg) is fertilized with the sperm (self-sperm or donor’s sperm). The fertilized egg or embryo is then implanted into the uterus.

The market growth is attributed to the reduced conceiving rates, mainly in women aged 40 years or above, ovulation disorder, premature ovarian failure, uterine fibroids, damaged or blocked fallopian tube, endometriosis, impaired sperm production or function and unexplained infertility. The encouraging factors such as increase in government interventions and support and delayed parenthood opted by couples due to professional and financial constraints are expected to fuel the market growth. However, ethical concerns in particular countries with respect to IVF, high cost of the IVF procedure, followed by low awareness, especially in underdeveloped economies are expected to hinder the market growth.

This report segments the world IVF market on the basis of cycle type, end user, and geography. On the basis of cycle type, market is classified into fresh cycle (non-donor), thawed IVF cycle (non-donor), and donor egg IVF cycles. Fresh cycle (non-donor) is the highest revenue-generating segment, and is expected to maintain this trend with a high growth rate throughout the analysis period. As it is the most common method in an IVF process. Similarly, by end user, the market is segmented into fertility clinics, hospitals, surgical centers, and clinical research institutes. The geographical segmentation of the market includes North America, Europe, Asia-Pacific and LAMEA.

The report takes into account the costs of IVF procedures and the total revenue generated through IVF procedures. The total number of IVF cycles performed in the regional market is estimated from 2016 to 2023. This report presents data on the number of embryo transfers undergone by patients during IVF procedures. In addition, it depicts the trend analysis in various regions, which is expected to assist key players to plan their strategies. However, this report excludes revenue generated by fertility medications and the costs of other medication incurred during IVF treatments.

Geographical Market Scenario:

Geographically, the market is segmented across North America, Europe, Asia-Pacific, and LAMEA regions. In terms of number of IVF cycles performed, Asia-Pacific is estimated to dominate the global IVF market throughout the analysis period and is set to grow at a prominent CAGR of 13.6%, due to wide availability of IVF clinics, high IVF success rates, and the rising trend of fertility tourism. Japan leads the Asia-Pacific IVF services market, accounting for majority of the market share, and is expected to maintain its position during the analysis period.

 Get more information on this report : Request Sample Pages

Latin American countries such as Brazil, Colombia, and Venezuela do not provide reimbursements for ART treatment. In Argentina, currently, there is no reimbursement policy available for ARTs; however, partial reimbursements are provided for ovulation induction therapies. Most of the medical treatments in Latin American countries are provided in the public sector. Fertility clinics contributed to highest number of IVF cycles in 2015.

End User Market Scenario:

Fertility clinics accounted for a major market share in 2016, and is projected to maintain this trend over the forecast period. This is attributed to the rise in the number of fertility clinics as well as the availability of a wide range of fertility treatments under a single roof coupled with government reimbursements. Fertility clinics is followed by hospitals, and together they occupied over three-fourths share of the overall market share in 2016.

 Get more information on this report : Request Sample Pages

Market Drivers

Delayed Pregnancies

Trends of delaying pregnancy have steadily increased in Europe and many other countries. With the rising age, the eggs produced by women possess limited abilities of fertilization, which may lead to genetic disorders in the resultant embryos. According to CDC (centers for disease control and prevention), the rate of fertilization in the age group of 35-39 years through IVF procedure is considerably high.

Rise in Global Infertility Rates

In 2010, the World Health Organization (WHO) has estimated that, about 48.5 million couples across the world faces the problems of infertility. The WHO research further concluded that, about 1.9% of the couples between ages 20 to 44 years among the aforementioned population were unable to have the first live birth. Factors such as, smoking, unhealthy lifestyles, obesity, and the environmental factors contributing to high infertility rates. It is estimated that every year, one out of 25 men face the problems of low sperm counts across the globe, which may reduce the rates of live births. All of the aforementioned factors collectively boost the growth of the global IVF services market.

Key Benefits

  • The report provides an in-depth analysis of the IVF market across major countries, with a cross-sectional analysis of the number of IVF cycles performed and total revenue generated during the forecast period.
  • The report assists in understanding the strategies adopted by various IVF clinics and hospitals to gain a higher market share.
  • The projections in the report are made by analyzing the current trends and highlighting the market potential from 2017 to 2023, in terms of value and volume.
  • Extensive analysis is conducted by closely following key product positioning and monitoring the top contenders within the market framework.
  • In-depth analysis of insurance reimbursement scenario for the IVF procedure highlights the essential strengths and potential opportunities in the market.

In Vitro Fertilization (IVF) Services Market Key Segments:

By Cycle Type

  • Fresh Cycle (Non-Donor)
  • Thawed IVF Cycle (Non-Donor)
  • Donor Egg IVF Cycle

By End User

  • Fertility Clinics
  • Hospitals
  • Surgical Centers
  • Clinical Research Institutes

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • New Zealand
    • Korea
    • Thailand
    • Rest of Asia-Pacific
  • LAMEA
    • Latin America
    • Middle East
    • Africa
 

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

Chapter: 3 WORLD IN VITRO FERTILIZATION (IVF) MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. IVF PRICING TRENDS BY COUNTRY
3.3. IVF CYCLES BY COUNTRY
3.4. GLOBAL IVF MARKET BY END USERS

3.4.1. Fertility clinics
3.4.2. Hospitals
3.4.3. Surgical centers
3.4.4. Clinical research institutes

3.5. GLOBAL IVF MARKET BY CYCLE TYPE

3.5.1. Fresh IVF cycles (non-donor)
3.5.2. Thawed IVF cycles (non-donor)
3.5.3. Donor egg IVF cycles

3.6. MARKET DYNAMICS

3.6.1. Drivers

3.6.1.1. Delayed pregnancies
3.6.1.2. Rise in global infertility rates
3.6.1.3. Emergence of new fertility tourism destinations

3.6.2. Restraints

3.6.2.1. High Cost involved in the treatment
3.6.2.2. Low level of awareness in developing economies
3.6.2.3. Inadequate reimbursements policies for IVF treatments
3.6.2.4. Ethical Considerations

3.6.3. Opportunities

3.6.3.1. relaxing the legal considerations on ivf treatments
3.6.3.2. New technology development and treatment options
3.6.3.3. Three parent IVF

3.7. KEY FINDINGS

Chapter: 4 NORTH AMERICA IVF MARKET

4.1. UNITED STATES IVF MARKET, (REVENUE AND NUMBER OF CYCLES)

4.1.1. Number of Infertility Clinics, 2016
4.1.2. United States IVF Market by End Users

4.1.2.1. Fertility clinics
4.1.2.2. Hospitals
4.1.2.3. Surgical centers
4.1.2.4. Clinical research institutes

4.1.3. United States IVF market by cycle type

4.1.3.1. Fresh IVF cycles (non-donor)
4.1.3.2. Thawed IVF cycles (non-donor)
4.1.3.3. Donor egg IVF cycles

4.1.4. Drivers

4.1.4.1. Increasing popularity of IVF in United States
4.1.4.2. Increased rate of infertility and practices of embryo banking cycles

4.1.5. Restraints

4.1.5.1. High cost of IVF treatment in United Sates
4.1.5.2. Restrictions on 3-parent IVF treatments
4.1.5.3. Scattered Reimbursements

4.1.6. Regulatory Issues, Legislations and Authorities
4.1.7. Insurance Reimbursement Scenario
4.1.8. Company Profile

4.1.8.1. Fertility and Gynecology Center Monterey Bay IVF
4.1.8.2. Conceptions Reproductive Associates
4.1.8.3. Servy Massey Fertility Institute
4.1.8.4. Sher Institute for Reproductive Medicine (SIRM)
4.1.8.5. Cardone Reproductive Medicine & Infertility
4.1.8.6. Fertility Center of San Antonio
4.1.8.7. Houston Fertility Center
4.1.8.8. New hope fertility center
4.1.8.9. Reproductive Medicine Associates Of New Jersey

4.2. CANADA IVF MARKET (REVENUE AND NUMBER OF CYCLES)

4.2.1. Number of infertility centers
4.2.2. Canada IVF Market by End users

4.2.2.1. Fertility clinics
4.2.2.2. Hospitals
4.2.2.3. Surgical centers
4.2.2.4. Clinical research institutes

4.2.3. Canada IVF market by cycle type

4.2.3.1. Fresh IVF cycles (non-donor)
4.2.3.2. Thawed IVF cycles (non-donor)
4.2.3.3. Donor egg IVF cycles

4.2.4. Market Dynamics

4.2.4.1. Drivers

4.2.4.1.1. Commercialization of IVF booster in Canada

4.2.4.2. Restraints

4.2.4.2.1. High cost of IVF in Canada

4.2.5. Regulatory Issues, Legislations and Authorities
4.2.6. Insurance Reimbursement Scenario
4.2.7. Company Profile

4.2.7.1. Toronto Centre for Advanced Reproductive Technology Ltd.
4.2.7.2. Fertility Treatment Center
4.2.7.3. Montreal Fertility Center

4.3. MEXICO IVF MARKET (REVENUE AND NUMBER OF CYCLES)

4.3.1. Number of infertility centers
4.3.2. Mexico IVF Market by End Users

4.3.2.1. Fertility clinics
4.3.2.2. Hospitals
4.3.2.3. Surgical centers
4.3.2.4. Clinical research institutes

4.3.3. Mexico IVF market by cycle type

4.3.3.1. Fresh IVF cycles (non-donor)
4.3.3.2. Thawed IVF cycles (non-donor)
4.3.3.3. Donor egg IVF cycles

4.3.4. Market Dynamics

4.3.4.1. Drivers

4.3.4.1.1. Fertility tourism
4.3.4.1.2. Comparatively low cost of IVF

4.3.4.2. Restraints

4.3.4.2.1. Language Barriers

4.3.5. Regulatory Issues, Legislations and Authorities
4.3.6. Insurance Reimbursement Scenario
4.3.7. Company Profile

4.3.7.1. Liv Fertility Center In Puerto Vallarta
4.3.7.2. BFC Biofertility Center

Chapter: 5 EUROPE IVF MARKET (REVENUE AND NUMBER OF CYCLES)

5.1. GERMANY IVF MARKET (REVENUE AND NUMBER OF CYCLES)

5.1.1. Number of infertility clinics in Germany
5.1.2. Germany IVF Market by End Users

5.1.2.1. Fertility clinics
5.1.2.2. Hospitals
5.1.2.3. Surgical centers
5.1.2.4. Clinical research institutes

5.1.3. Germany IVF market by cycle type

5.1.3.1. Fresh IVF cycles (non-donor)
5.1.3.2. Thawed IVF cycles (non-donor)

5.1.4. Market Dynamics

5.1.4.1. Drivers

5.1.4.1.1. Subsidizing IVF treatments
5.1.4.1.2. Delayed Marriages and Parenthood decisions

5.1.4.2. Restraints

5.1.4.2.1. Limited adoption of IVF methods

5.1.5. Regulatory Issues, Legislations and Authorities
5.1.6. Insurance Reimbursement Scenario
5.1.7. Company Profile

5.1.7.1. Heidelberg University Hospital
5.1.7.2. Klinikum Stuttgart
5.1.7.3. DRK Kliniken Berlin
5.1.7.4. University Medical Center Freiburg

5.2. FRANCE IVF MARKET (REVENUE AND NUMBER OF CYCLES)

5.2.1. Number of infertility centers in France
5.2.2. France IVF Market by End Users

5.2.2.1. Fertility clinics
5.2.2.2. Hospitals
5.2.2.3. Surgical centers
5.2.2.4. Clinical research institutes

5.2.3. France IVF market by cycle type

5.2.3.1. Fresh IVF cycles (non-donor)
5.2.3.2. Thawed IVF cycles (non-donor)
5.2.3.3. Donor egg IVF cycles

5.2.4. Market Dynamics

5.2.4.1. Drivers

5.2.4.1.1. Rising adoption of IVF babies among same gender population
5.2.4.1.2. Lower rates of Fertility

5.2.4.2. Restraints

5.2.4.2.1. Stringent Government regulations

5.2.5. Regulatory Issues, Legislations and Authorities
5.2.6. Insurance Reimbursement Scenario
5.2.7. Company Profile

5.2.7.1. Clinique de la Muette
5.2.7.2. Hopital des metallurgists, hopital cochin

5.3. UNITED KINGDOM IVF MARKET (REVENUE AND NUMBER OF CYCLES)

5.3.1. Number of infertility centers in United Kingdom
5.3.2. United Kingdom IVF Market by End Users

5.3.2.1. Fertility clinics
5.3.2.2. Hospitals
5.3.2.3. Surgical centers
5.3.2.4. Clinical research institutes

5.3.3. United Kingdom IVF market by cycle type

5.3.3.1. Fresh IVF cycles (non-donor)
5.3.3.2. Thawed IVF cycles (non-donor)
5.3.3.3. Donor egg IVF cycles

5.3.4. Drivers

5.3.4.1. Commercialization of three-parent IVF procedures
5.3.4.2. Supportive Regulations

5.3.5. Restraints

5.3.5.1. Ethical Considerations

5.3.6. Regulatory Issues, Legislations and Authorities
5.3.7. Insurance Reimbursement Scenario
5.3.8. Company Profile

5.3.8.1. Lister Fertility Clinic
5.3.8.2. The Bridge Center
5.3.8.3. Chelsea and Westminster Hospital (Assisted Conception Unit)

5.4. ITALY IVF MARKET (REVENUE AND NUMBER OF CYCLES)

5.4.1. Italy IVF market by End users

5.4.1.1. Fertility clinics
5.4.1.2. Hospitals
5.4.1.3. Surgical centers
5.4.1.4. Clinical research institutes

5.4.2. Italy IVF market by cycle type

5.4.2.1. Fresh IVF cycles (non-donor)
5.4.2.2. Thawed IVF cycles (non-donor)

5.4.3. Market Dynamics

5.4.3.1. Drivers
5.4.3.2. Restraints

5.4.3.2.1. Ban on the Surrogacy

5.4.4. Regulatory issues, legislations and authorities
5.4.5. Insurance Reimbursement Scenario
5.4.6. Company Profile

5.4.6.1. ARC-STER srl
5.4.6.2. RAPRUI
5.4.6.3. Centre for Reproductive Medicine-Napoli

5.5. SPAIN IVF MARKET (REVENUE AND NUMBER OF CYCLES)

5.5.1. Spain IVF Market by End Users

5.5.1.1. Fertility clinics
5.5.1.2. Hospitals
5.5.1.3. Surgical centers
5.5.1.4. Clinical research institutes

5.5.2. Spain IVF Market by Cycle Type

5.5.2.1. Fresh IVF cycles (non-donor)
5.5.2.2. Thawed IVF cycles (non-donor)
5.5.2.3. Donor egg IVF cycles

5.5.3. Market Dynamics

5.5.3.1. Drivers

5.5.3.1.1. Increase in the number of foreign patients

5.5.3.2. Restraints

5.5.4. Regulatory Issues, Legislations and Authorities
5.5.5. Insurance Reimbursement Scenario
5.5.6. Company Profiles

5.5.6.1. IVF spain
5.5.6.2. Clínica EUGIN Barcelona

5.6. DENMARK IVF MARKET (REVENUE AND NUMBER OF CYCLES)

5.6.1. Denmark IVF Market by End Users

5.6.1.1. Fertility clinics
5.6.1.2. Hospitals
5.6.1.3. Surgical centers
5.6.1.4. Clinical research institutes

5.6.2. Denmark IVF market by cycle type

5.6.2.1. Fresh IVF cycles (non-donor)
5.6.2.2. Thawed IVF cycles (non-donor)
5.6.2.3. Donor egg IVF cycles

5.6.3. Drivers

5.6.3.1. Increase in disposable income
5.6.3.2. Advances in IVF technology

5.6.4. Restraints
5.6.5. Regulatory Issues, Legislations and Authorities
5.6.6. Insurance Reimbursement Scenario
5.6.7. Company Profiles

5.6.7.1. Copenhagen Fertility Center
5.6.7.2. Storkklinik v/Nina Stork
5.6.7.3. Vitanova
5.6.7.4. trianglen fertility clinic
5.6.7.5. Nordica - Denmark, Copenhagen

5.7. RUSSIA IVF MARKET (REVENUE AND NUMBER OF CYCLES)

5.7.1. Russia IVF Market by End Users

5.7.1.1. Fertility clinics
5.7.1.2. Hospitals
5.7.1.3. Surgical centers
5.7.1.4. Clinical research institutes

5.7.2. Russia IVF market by cycle type

5.7.2.1. Fresh IVF cycles (non-donor)
5.7.2.2. Thawed IVF cycles (non-donor)
5.7.2.3. Donor egg IVF cycles

5.7.3. Drivers

5.7.3.1. Rising popularity of fertility tourism

5.7.4. Restraints

5.7.4.1. Inadequate reimbursement policies

5.7.5. Regulatory Issues, Legislations and Authorities
5.7.6. Insurance Reimbursement Scenario
5.7.7. Company Profiles

5.7.7.1. ava-peter clinic
5.7.7.2. MD medical group
5.7.7.3. IVF Russia (The International Centre of the Reproductive Medicines)

5.8. REST OF EUROPE IVF MARKET (REVENUE AND NUMBER OF CYCLES)

5.8.1. Rest of Europe IVF Market by End Users

5.8.1.1. Fertility clinics
5.8.1.2. Hospitals
5.8.1.3. Surgical centers
5.8.1.4. Clinical research institutes

5.8.2. Rest of Europe IVF market by cycle type

5.8.2.1. Fresh IVF cycles (non-donor)
5.8.2.2. Thawed IVF cycles (non-donor)
5.8.2.3. Donor egg IVF cycles

5.8.3. Drivers

5.8.3.1. Wide availability of reimbursements
5.8.3.2. Changes in Lifestyle

5.8.4. Restraints
5.8.5. Regulatory Issues, Legislations and Authorities
5.8.6. Insurance Reimbursement Scenario
5.8.7. Company Profiles

5.8.7.1. Gynaecoloqisch Centrum
5.8.7.2. Centrum voor medische genetica
5.8.7.3. Infertility-Väestöliitto

Chapter: 6 ASIA-PACIFIC IVF MARKET (REVENUE AND NUMBER OF CYCLES)

6.1. INDIA IVF MARKET (REVENUE AND NUMBER OF CYCLES)

6.1.1. India IVF Market by End Users

6.1.1.1. Fertility clinics
6.1.1.2. Hospitals
6.1.1.3. Surgical centers
6.1.1.4. Clinical research institutes

6.1.2. India IVF market by cycle type

6.1.2.1. Fresh IVF cycles (non-donor)
6.1.2.2. Thawed IVF cycles (non-donor)
6.1.2.3. Donor egg IVF cycles

6.1.3. Market Dynamics

6.1.3.1. Drivers
6.1.3.2. Restraints

6.1.4. Regulatory Issues, Legislations and Authorities
6.1.5. Insurance Reimbursement Scenario
6.1.6. Company Profile

6.1.6.1. Bourn Hall Clinic
6.1.6.2. Southend Fertility and IVF Centre
6.1.6.3. Morpheus IVF Fertility Center
6.1.6.4. Bloom Fertility Center
6.1.6.5. Manipal Ankur
6.1.6.6. Cloudnine
6.1.6.7. Nova IVI Fertility

6.2. CHINA IVF MARKET (REVENUE AND NUMBER OF CYCLES)

6.2.1. China IVF Market by End User

6.2.1.1. Fertility clinics
6.2.1.2. Hospitals
6.2.1.3. Surgical centers
6.2.1.4. Clinical research institutes

6.2.2. China IVF market by cycle type

6.2.2.1. Fresh IVF cycles (non-donor)
6.2.2.2. Thawed IVF cycles (non-donor)
6.2.2.3. Donor egg IVF cycles

6.2.3. Market Dynamics

6.2.3.1. Drivers

6.2.3.1.1. Change in lifestyle

6.2.3.2. Restraints

6.2.3.2.1. One child policy

6.2.4. Regulatory Issues, Legislations and Authorities
6.2.5. Insurance Reimbursement Scenario
6.2.6. Company profile

6.2.6.1. Reproductive and genetic Hospital Citic-Xiangya
6.2.6.2. Shenyang Hospital
6.2.6.3. Shandong Provincial Hospital
6.2.6.4. Centre for Reproductive Medicine

6.3. JAPAN IVF MARKET (REVENUE AND NUMBER OF CYCLES)

6.3.1. Japan IVF Market by End-Users

6.3.1.1. Fertility clinics
6.3.1.2. Hospitals
6.3.1.3. Surgical centers
6.3.1.4. Clinical research institutes

6.3.2. Japan IVF market by cycle type

6.3.2.1. Fresh IVF cycles (non-donor)
6.3.2.2. Thawed IVF cycles (non-donor)

6.3.3. Market Dynamics

6.3.3.1. Drivers
6.3.3.2. Restraints

6.3.4. Regulatory Issues, Legislations and Authorities
6.3.5. Insurance Reimbursement Scenario
6.3.6. Company Profile

6.3.6.1. EMD Serono, Inc
6.3.6.2. IVF NAMBA Clinic
6.3.6.3. Iwaki Women’s Clinic
6.3.6.4. Sanno Hospital

6.4. AUSTRALIA IVF MARKET (REVENUE AND NUMBER OF CYCLES)

6.4.1. Australia IVF Market by End Users

6.4.1.1. Fertility clinics
6.4.1.2. Hospitals
6.4.1.3. Surgical centers
6.4.1.4. Clinical research institutes

6.4.2. Australia IVF market by cycle type

6.4.2.1. Fresh IVF cycles (non-donor)
6.4.2.2. Thawed IVF cycles (non-donor)

6.4.3. Market Dynamics

6.4.3.1. Drivers
6.4.3.2. Restraints

6.4.3.2.1. Emotional and physical stress
6.4.3.2.2. No guarantee for the successful treatments
6.4.3.2.3. Surplus embryos

6.4.4. Regulatory Issues, Legislations and Authorities
6.4.5. Insurance Reimbursement Scenario
6.4.6. Company Profile

6.4.6.1. Genea Biomedx
6.4.6.2. Thermo Fisher Scientific Inc.
6.4.6.3. Virtus Health limited
6.4.6.4. Monash IVF
6.4.6.5. City Fertility center, brisbane
6.4.6.6. Flinders Fertility clinic

6.5. NEW ZEALAND IVF MARKET (REVENUE AND NUMBER OF CYCLES)

6.5.1. New Zealand IVF Market by End users

6.5.1.1. Fertility clinics
6.5.1.2. Hospitals
6.5.1.3. Surgical centers
6.5.1.4. Clinical research institutes

6.5.2. New Zealand IVF Market by Cycle Type

6.5.2.1. Fresh IVF cycles (non-donor)
6.5.2.2. Thawed IVF cycles (non-donor)
6.5.2.3. Donor egg IVF cycles

6.5.3. Market Dynamics

6.5.3.1. Drivers
6.5.3.2. Restraints

6.5.4. Regulatory Issues, Legislations and Authorities
6.5.5. Insurance Reimbursement Scenario
6.5.6. Company Profiles

6.5.6.1. Fertility Associates
6.5.6.2. Fertility Plus
6.5.6.3. Repromed

6.6. KOREA IVF MARKET (REVENUE AND NUMBER OF CYCLES)

6.6.1. Korea IVF Market by End Users

6.6.1.1. Fertility clinics
6.6.1.2. Hospitals
6.6.1.3. Surgical centers
6.6.1.4. Clinical research institutes

6.6.2. Korea IVF market by cycle type

6.6.2.1. Fresh IVF cycles (non-donor)
6.6.2.2. Thawed IVF cycles (non-donor)
6.6.2.3. Donor egg IVF cycles

6.6.3. Market Dynamics

6.6.3.1. Drivers
6.6.3.2. Restraints

6.6.4. Regulatory Issues, legislations and Authorities
6.6.5. Insurance Reimbursement Scenario
6.6.6. Company Profiles

6.6.6.1. Cha General Hospital
6.6.6.2. MARIA Fertility Hospital

6.7. THAILAND IVF MARKET (REVENUE AND NUMBER OF CYCLES)

6.7.1. Thailand IVF Market by End Users

6.7.1.1. Fertility clinics
6.7.1.2. Hospitals
6.7.1.3. Surgical centers
6.7.1.4. Clinical research institutes

6.7.2. Thailand IVF market by cycle type

6.7.2.1. Fresh IVF cycles (non-donor)
6.7.2.2. Thawed IVF cycles (non-donor)
6.7.2.3. Market Dynamics
6.7.2.4. Drivers

6.7.2.4.1. Government initiatives
6.7.2.4.2. Economic considerations
6.7.2.4.3. Boost in medical tourism

6.7.2.5. Restraints

6.7.2.5.1. Comparatively low success rate
6.7.2.5.2. Ethical issues in allowing gender selection

6.7.3. Regulatory Issues, legislations and Authorities
6.7.4. Insurance Reimbursement Scenario
6.7.5. Company Profiles

6.7.5.1. Bangkok Fertility Center
6.7.5.2. Siriraj Hospital
6.7.5.3. Ramathibodi Hospital
6.7.5.4. Perfect Woman Institute
6.7.5.5. Jetanin Institute for Assisted Reproduction

6.8. OTHER ASIA-PACIFIC IVF MARKET (REVENUE AND NUMBER OF CYCLES)

6.8.1. Other Asia-Pacific IVF Market by End Users

6.8.1.1. Fertility clinics
6.8.1.2. Hospitals
6.8.1.3. Surgical centers
6.8.1.4. Clinical research institutes

6.8.2. Other Asia-Pacific IVF market by cycle type

6.8.2.1. Fresh IVF cycles (non-donor)
6.8.2.2. Thawed IVF cycles (non-donor)
6.8.2.3. Donor egg IVF cycles

6.8.3. Drivers

6.8.3.1. Increase in disposable income
6.8.3.2. Advances in IVF technology
6.8.3.3. Decline in fertility rate

6.8.4. Restraints

6.8.4.1. Physical and emotional impact due to low success rate

6.8.5. Regulatory Issues, legislations and Authorities
6.8.6. Insurance Reimbursement Scenario
6.8.7. Company Profiles

6.8.7.1. Fertility Centre, Siloam Hospitals Surabana
6.8.7.2. CRM-MIA-Philippines
6.8.7.3. IVFAS

Chapter: 7 LAMEA IVF MARKET (REVENUE AND NUMBER OF CYCLES)

7.1. LATIN AMERICA IVF MARKET (REVENUE AND NUMBER OF CYCLES)

7.1.1. Number of Infertility Centers
7.1.2. Latin America IVF Market by End users

7.1.2.1. Fertility clinics
7.1.2.2. Hospitals
7.1.2.3. Surgical centers
7.1.2.4. Clinical research institutes

7.1.3. Latin America IVF market by cycle type

7.1.3.1. Fresh IVF cycles (non-donor)
7.1.3.2. Thawed IVF cycles (non-donor)
7.1.3.3. Donor egg IVF cycles

7.1.4. Drivers

7.1.4.1. Rising Medical Tourism in Latin American Countries
7.1.4.2. Permission for IVF treatments in Costa Rica

7.1.5. Restraints

7.1.5.1. High infant mortality rates in Brazil

7.1.6. Regulatory Issues, legislations and Authorities
7.1.7. Insurance Reimbursement Scenario
7.1.8. Profiles of Major Players

7.1.8.1. Clinica Anglo Americana
7.1.8.2. IVF Panama Centro De Reproduccion
7.1.8.3. Insemer
7.1.8.4. Almater Hospital
7.1.8.5. San Fernando Hospital

7.2. MIDDLE EAST IVF MARKET (REVENUE AND NUMBER OF CYCLES)

7.2.1. Number of infertility centers
7.2.2. Middle East IVF Market by End users

7.2.2.1. Fertility clinics
7.2.2.2. Hospitals
7.2.2.3. Surgical centers
7.2.2.4. Clinical research institutes

7.2.3. Middle East IVF market by Cycle Type

7.2.3.1. Fresh IVF cycles (non-donor)
7.2.3.2. Thawed IVF cycles (non-donor)
7.2.3.3. Donor egg IVF cycles

7.2.4. Market Dynamics

7.2.4.1. Drivers

7.2.4.1.1. High-tech culture in the Middle East countries
7.2.4.1.2. Availability of Reimbursements

7.2.4.2. Restraints

7.2.4.2.1. Stringent government regulations in Middle East Regions

7.2.5. Regulatory Issues, Legislations and Authorities
7.2.6. Insurance Reimbursement Scenario
7.2.7. Company Profile

7.2.7.1. Cyprus IVF Centre
7.2.7.2. Al Bushra Medical Specialty Complex
7.2.7.3. Reproductive Medicine Unit at Corniche Hospital (Corniche Fertility center)
7.2.7.4. Trakya University Hospital ART Center

7.3. AFRICA IVF MARKET (REVENUE AND NUMBER OF CYCLES)

7.3.1. Number of infertility centers
7.3.2. Africa IVF Market by End users

7.3.2.1. Fertility clinics
7.3.2.2. Hospitals
7.3.2.3. Surgical centers
7.3.2.4. Clinical research institutes

7.3.3. Africa IVF market by Cycle Type

7.3.3.1. Fresh IVF cycles (non-donor)
7.3.3.2. Thawed IVF cycles (non-donor)
7.3.3.3. Donor egg IVF cycles

7.3.4. Drivers

7.3.4.1. Low costs of IVF treatment
7.3.4.2. Rising Fertility Tourism in South Africa

7.3.5. Restraints

7.3.5.1. Susceptibility toward fibroids

7.3.6. Regulatory Issues, legislations and Authorities
7.3.7. Insurance Reimbursement Scenario
7.3.8. Company Profile

7.3.8.1. Lifesure Fertility & Gynaecology Centre
7.3.8.2. Bethany Women and Family Hospital
7.3.8.3. BioART Fertility Centre
7.3.8.4. DEL International Hospital & Fertility Centre
7.3.8.5. Gift ov life
7.3.8.6. Durban Fertility Clinic
7.3.8.7. Cape fertility clinic

LIST OF TABLES

TABLE 1. IVF PRICING TRENDS, BY COUNTRY, 2016
TABLE 2. GLOBAL IVF MARKET, BY COUNTRY, 2016-2023 (THOUSAND)
TABLE 3. GLOBAL IVF MARKET, BY END USERS, 2016-2023 (THOUSAND)
TABLE 4. GLOBAL IVF MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 5. GLOBAL IVF MARKET, BY CYCLE TYPE, 2016-2023 (THOUSAND)
TABLE 6. GLOBAL IVF MARKET, BY CYCLE TYPE, 2016-2023 ($MILLION)
TABLE 7. IVF SUCCESS RATES ACCORDING TO AGE
TABLE 8. NORTH AMERICA IVF MARKET, BY COUNTRY 2016-2023 (THOUSAND)
TABLE 9. NORTH AMERICA IVF MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 10. FRESH EMBRYO TRANSFER FROM NON-DONOR OOCYTES, UNITED STATES, 2015
TABLE 11. THAWED EMBRYO TRANSFER FROM NON-DONOR OOCYTES, UNITED STATES, 2015
TABLE 12. DONOR OOCYTES (FOR ALL AGES), UNITED STATES, 2015
TABLE 13. UNITED STATES IVF MARKET, VOLUME AND VALUE, 2016 - 2023 (THOUSAND AND $MILLION)
TABLE 14. NUMBER OF FERTILITY CLINICS IN UNITED STATES (2016)
TABLE 15. UNITED STATES IVF MARKET, BY END USERS, 2016 - 2023 (THOUSAND)
TABLE 16. UNITED STATES IVF MARKET, BY END USERS, 2016 - 2023 ($MILLION)
TABLE 17. UNITED STATES IVF MARKET BY CYCLE TYPE, 2016-2023 ($MILLION)
TABLE 18. UNITED STATES IVF MARKET BY CYCLE TYPE, 2016-2023 (THOUSAND)
TABLE 19. FERTILITY AND GYNECOLOGY CENTER MONTEREY BAY IVF BUSINESS OVERVIEW
TABLE 20. SNAPSHOT OF FERTILITY AND GYNECOLOGY CENTER MONTEREY BAY
TABLE 21. CONCEPTIONS REPRODUCTIVE ASSOCIATES BUSINESS OVERVIEW
TABLE 22. SNAPSHOT OF CONCEPTIONS REPRODUCTIVE ASSOCIATES
TABLE 23. SERVY MASSEY FERTILITY INSTITUTE BUSINESS OVERVIEW
TABLE 24. SNAPSHOT OF SERVY MASSEY FERTILITY INSTITUTE
TABLE 25. SHER INSTITUTE FOR REPRODUCTIVE MEDICINE (SIRM)BUSINESS OVERVIEW
TABLE 26. SNAPSHOT OF INSTITUTE FOR REPRODUCTIVE MEDICINE (SIRM)
TABLE 27. CARDONE REPRODUCTIVE MEDICINE & INFERTILITY BUSINESS OVERVIEW
TABLE 28. SNAPSHOT OF CARDONE REPRODUCTIVE MEDICINE & INFERTILITY
TABLE 29. FERTILITY CENTER OF SAN ANTONIO BUSINESS OVERVIEW
TABLE 30. SNAPSHOT OF FERTILITY CENTER OF SAN ANTONIO
TABLE 31. HOUSTON FERTILITY CENTER BUSINESS OVERVIEW
TABLE 32. SNAPSHOT OF HOUSTON FERTILITY CENTER
TABLE 33. NEW HOPE FERTILITY CENTER BUSINESS OVERVIEW
TABLE 34. SNAPSHOT OF HOUSTON FERTILITY CENTER
TABLE 35. REPRODUCTIVE MEDICINE ASSOCIATES OF NEW JERSEY BUSINESS OVERVIEW
TABLE 36. SNAPSHOT OF HOUSTON FERTILITY CENTER
TABLE 37. SUMMARY FOR IVF PROCEDURES, CANADA, 2015
TABLE 38. CYCLE OUTCOMES FOR IVF PROCEDURES, CANADA, 2015
TABLE 39. CANADA IVF MARKET, VOLUME AND VALUE, 2016 - 2023 (THOUSAND AND $MILLION)
TABLE 40. CANADA IVF MARKET, BY END USERS, 2016-2023 (THOUSAND)
TABLE 41. CANADA IVF MARKET BY END USERS, 2016-2023 ($MILLION)
TABLE 42. CANADA IVF MARKET, BY CYCLE TYPE, 2016-2023 ($MILLION)
TABLE 43. CANADA IVF MARKET BY CYCLE TYPE, 2016-2023 (THOUSAND)
TABLE 44. BUSINESS OVERVIEW
TABLE 45. SNAPSHOT OF TORONTO CENTRE FOR ADVANCED REPRODUCTIVE TECHNOLOGY LTD.
TABLE 46. FERTILITY TREATMENT CENTER BUSINESS OVERVIEW
TABLE 47. SNAPSHOT OF FERTILITY TREATMENT CENTER
TABLE 48. FERTILITY TREATMENT CENTER BUSINESS OVERVIEW
TABLE 49. SNAPSHOT OF FERTILITY TREATMENT CENTER
TABLE 50. MEXICO IVF MARKET, VOLUME AND VALUE, 2016-2023 (THOUSAND AND $MILLION)
TABLE 51. MEXICO IVF MARKET, BY END USERS, 2016-2023 (THOUSAND)
TABLE 52. MEXICO IVF MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 53. MEXICO IVF MARKET BY CYCLE TYPE, 2016-2023 ($MILLION)
TABLE 54. MEXICO IVF MARKET BY CYCLE TYPE, 2016-2023 (THOUSAND)
TABLE 55. LIV FERTILITY CENTER IN PUERTO VALLARTA BUSINESS OVERVIEW
TABLE 56. SNAPSHOT OF FERTILITY TREATMENT CENTER
TABLE 57. BIOFERTILITY CENTER IN GUDALAJARA BUSINESS OVERVIEW
TABLE 58. SNAPSHOT OF FERTILITY TREATMENT CENTER
TABLE 59. EUROPE IVF SERVICE MARKET, BY COUNTRY, 2016-2023 (THOUSAND)
TABLE 60. EUROPE IVF MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 61. GERMANY IVF SERVICE MARKET, VOLUME AND VALUE, 2016 - 2023 (THOUSAND AND $MILLION)
TABLE 62. GERMANY IVF MARKET, BY END USERS, 2016-2023 (THOUSAND)
TABLE 63. GERMANY IVF MARKET BY END USERS, 2016-2023 ($MILLION)
TABLE 64. GERMANY IVF MARKET, VALUE, 2016 - 2023 ($ MILLION)
TABLE 65. GERMANY IVF MARKET, VALUE, 2016 - 2023 (THOUSAND)
TABLE 66. HEIDELBERG UNIVERSITY HOSPITAL BUSINESS OVERVIEW
TABLE 67. SNAPSHOT OF HEIDELBERG UNIVERSITY HOSPITAL
TABLE 68. KLINIKUM STUTTGART BUSINESS OVERVIEW
TABLE 69. COMPANY SNAPSHOT
TABLE 70. DRK KLINIKEN BERLIN BUSINESS OVERVIEW
TABLE 71. SNAPSHOT OF DRK KLINIKEN BERLIN
TABLE 72. UNIVERSITY MEDICAL CENTER FREIBURG BUSINESS OVERVIEW
TABLE 73. SNAPSHOT OF UNIVERSITY MEDICAL CENTER FREIBURG
TABLE 74. FRANCE IVF MARKET, VOLUME AND VALUE, 2016 - 2023 (THOUSAND AND $MILLION)
TABLE 75. FRANCE IVF MARKET, BY END USERS, 2016-2023 (THOUSAND)
TABLE 76. FRANCE IVF MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 77. FRANCE IVF MARKET, BY CYCLE TYPE, 2016-2023 ($MILLION)
TABLE 78. FRANCE IVF MARKET, BY CYCLE TYPE, 2016-2023 (THOUSAND)
TABLE 79. CLINIQUE DE LA MUETTE BUSINESS OVERVIEW
TABLE 80. SNAPSHOT OF CLINIQUE DE LA MUETTE
TABLE 81. HOPITAL DES METALLURGISTS, HOPITAL COCHIN BUSINESS OVERVIEW
TABLE 82. SNAPSHOT OF HOPITAL DES METALLURGISTS, HOPITAL COCHIN
TABLE 83. IVF CYCLES BY VARIOUS AGE GROUPS, UNITED KINGDOM, 2015
TABLE 84. PROPORTION OF IVF CYCLES USING FRESH AND FROZEN EGGS, UNITED KINGDOM, 2015-2016
TABLE 85. IVF SUCCESS RATES IN UNITED KINGDOM (AS PER NHS), 2015
TABLE 86. REGIONAL IVF CLINICS AND TOTAL NUMBER OF WOMEN TREATED, UNITED KINGDOM, 2015
TABLE 87. UNITED KINGDOM IVF MARKET, VOLUME AND VALUE, 2016 - 2023 (THOUSAND AND $MILLION)
TABLE 88. UNITED KINGDOM IVF MARKET, BY END USERS, 2016-2023 (THOUSAND)
TABLE 89. UNITED KINGDOM IVF MARKET BY END USERS, 2016-2023 ($MILLION)
TABLE 90. UNITED KINGDOM IVF MARKET BY CYCLE TYPE, 2016-2023 ($MILLION)
TABLE 91. UNITED KINGDOM IVF MARKET BY CYCLE TYPE, 2016-2023 (THOUSAND)
TABLE 92. LISTER FERTILITY CLINIC BUSINESS OVERVIEW
TABLE 93. COMPANY SNAPSHOT
TABLE 94. THE BRIDGE CENTER BUSINESS OVERVIEW
TABLE 95. SNAPSHOT OF THE BRIDGE CENTER
TABLE 96. CHELSEA AND WESTMINSTER HOSPITAL BUSINESS OVERVIEW
TABLE 97. SNAPSHOT OF CHELSEA AND WESTMINSTER HOSPITAL
TABLE 98. ITALY IVF MARKET, VOLUME AND VALUE, 2016-2023 (THOUSAND AND $MILLION)
TABLE 99. ITALY IVF MARKET BY END USERS, 2016-2023 ($MILLION)
TABLE 100. ITALY IVF MARKET, BY END USERS, 2016-2023 (THOUSAND)
TABLE 101. ITALY IVF MARKET BY CYCLE TYPE, 2016-2023 ($MILLION)
TABLE 102. ITALY IVF MARKET BY CYCLE TYPE, 2016-2023 (THOUSAND)
TABLE 103. SPAIN IVF MARKET, VOLUME AND VALUE, 2016 - 2023 (THOUSAND AND $MILLION)
TABLE 104. SPAIN IVF MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 105. SPAIN IVF MARKET, BY END USERS, 2016-2023 (THOUSAND)
TABLE 106. SPAIN IVF MARKET BY CYCLE TYPE, 2016-2023 ($MILLION)
TABLE 107. SPAIN IVF MARKET BY CYCLE TYPE, 2016-2023 (THOUSAND)
TABLE 108. DENMARK IVF CYCLES, VOLUME AND VALUE, 2016-2023 (THOUSAND AND $MILLION)
TABLE 109. DENMARK IVF MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 110. DENMARK IVF MARKET, BY END USERS, 2016-2023 (THOUSAND)
TABLE 111. DENMARK IVF MARKET, BY CYCLE TYPE, 2016-2023 ($MILLION)
TABLE 112. DENMARK IVF MARKET, BY CYCLE TYPE, 2016-2023 (THOUSAND)
TABLE 113. RUSSIA IVF MARKET, VOLUME AND VALUE, 2016-2023 (THOUSAND AND $MILLION)
TABLE 114. RUSSIA IVF MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 115. RUSSIA IVF MARKET, BY END USERS, 2016-2023 (THOUSAND)
TABLE 116. RUSSIA IVF MARKET, BY CYCLE TYPE, 2016-2023 ($MILLION)
TABLE 117. RUSSIA IVF MARKET, BY CYCLE TYPE, 2016-2023 (THOUSAND)
TABLE 118. REST OF EUROPE IVF MARKET, VOLUME AND VALUE, 2016-2023 (THOUSAND AND $MILLION)
TABLE 119. REST OF EUROPE IVF MARKET REVENUE BY END USERS, 2016-2023 ($MILLION)
TABLE 120. OTHER EUROPE IVF CYCLES BY END USERS, 2016-2023 (THOUSAND)
TABLE 121. REST OF EUROPE IVF MARKET, BY CYCLE TYPE, 2016-2023 ($MILLION)
TABLE 122. RUSSIA IVF MARKET, BY CYCLE TYPE, 2016-2023 (THOUSAND)
TABLE 123. ASIA-PACIFIC IVF MARKET, BY COUNTRY, 2016 - 2023 (THOUSAND)
TABLE 124. ASIA-PACIFIC IVF MARKET, BY COUNTRY, 2016 - 2023 ($MILLION)
TABLE 125. INDIA IVF MARKET, VOLUME AND VALUE, 2016 - 2023 (THOUSAND AND $MILLION)
TABLE 126. INDIA IVF MARKET, BY END USERS, 2016 - 2023 (THOUSAND)
TABLE 127. INDIA IVF MARKET, BY END USERS, 2016 - 2023 ($MILLION)
TABLE 128. INDIA IVF MARKET, BY CYCLE TYPE, 2016-2023 ($MILLION)
TABLE 129. INDIA IVF MARKET BY CYCLE TYPE, 2016-2023 (THOUSAND)
TABLE 130. BOURN HALL BUSINESS OVERVIEW
TABLE 131. SOUTHEND FERTILITY AND IVF CENTRE BUSINESS OVERVIEW
TABLE 132. MORPHEUS IVF FERTILITY CENTER BUSINESS OVERVIEW
TABLE 133. BLOOM FERTILITY CENTER BUSINESS OVERVIEW
TABLE 134. MANIPAL ANKUR BUSINESS OVERVIEW
TABLE 135. CLOUDNINE BUSINESS OVERVIEW
TABLE 136. NOVA IVI FERTILITY BUSINESS OVERVIEW
TABLE 137. CHINA IVF MARKET, VOLUME AND VALUE, 2016-2023 (THOUSAND AND $MILLION)
TABLE 138. CHINA IVF MARKET, BY END USERS, 2016-2023 (THOUSAND)
TABLE 139. CHINA IVF MARKET BY END USERS, 2016-2023 ($MILLION)
TABLE 140. CHINA IVF MARKET, BY CYCLE TYPE, 2016-2023 ($MILLION)
TABLE 141. CHINA IVF MARKET, BY CYCLE TYPE, 2016-2023 (THOUSAND)
TABLE 142. REPRODUCTIVE AND GENETIC HOSPITAL CITIC-XIANGYA, BUSINESS OVERVIEW
TABLE 143. SHENYANG HOSPITAL BUSINESS OVERVIE
TABLE 144. SHANDONG PROVINCIAL HOSPITAL BUSINESS OVERVIEW
TABLE 145. CENTRE FOR REPRODUCTIVE MEDICINE, BUSINESS OVERVIEW
TABLE 146. JAPAN IVF MARKET, VOLUME AND VALUE, 2016 - 2023 (THOUSAND AND $MILLION)
TABLE 147. JAPAN IVF MAKET, BY END USERS, 2016-2023 (THOUSAND)
TABLE 148. JAPAN IVF MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 149. JAPAN IVF MARKET BY CYCLE TYPE, 2016-2023 ($MILLION)
TABLE 150. JAPAN IVF MARKET BY CYCLE TYPE, 2016-2023 (THOUSAND)
TABLE 151. EMD SERONO INC BUSINESS OVERVIEW
TABLE 152. SNAPSHOT OF EMD SERONO INC
TABLE 153. IVF NAMBA CLINIC BUSINESS OVERVIEW
TABLE 154. IWAKI WOMEN’S CLINIC BUSINESS OVERVIEW
TABLE 155. SANNO HOSPITAL BUSINESS OVERVIEW
TABLE 156. AUSTRALIA IVF MARKET, VOLUME AND VALUE, 2016-2023 (THOUSAND AND $MILLION)
TABLE 157. OUTCOMES OF CYCLES OF IVF BY WOMEN’S AGE GROUP, 2015
TABLE 158. AUSTRALIA IVF MARKET, BY END USERS, 2016-2023 (THOUSAND)
TABLE 159. AUSTRALIA IVF MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 160. AUSTRALIA IVF MARKET BY CYCLE TYPE, 2016-2023 ($MILLION)
TABLE 161. AUSTRALIA IVF MARKET BY CYCLE TYPE, 2016-2023 (THOUSAND)
TABLE 162. GENEA BIOMEDX TECHNOLOGIES BUSINESS OVERVIEW
TABLE 163. SNAPSHOT OF GENEA BIOMEDX TECHNOLOGIES
TABLE 164. THERMO FISHER SCIENTIFIC INC. BUSINESS OVERVIEW
TABLE 165. SNAPSHOT OF THERMO FISHER SCIENTIFIC INC.
TABLE 166. VIRTUS HEALTH BUSINESS OVERVIEW
TABLE 167. MONASH IVF BUSINESS OVERVIEW
TABLE 168. CITY FERTILITY BUSINESS OVERVIEW
TABLE 169. FLINDERS FERTILITY BUSINESS OVERVIEW
TABLE 170. NEW ZEALAND IVF MARKET, VOLUME AND VALUE, 2016-2023 (THOUSAND AND $MILLION)
TABLE 171. NEW ZEALAND IVF MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 172. NEW ZEALAND IVF MARKET, BY END USERS, 2016-2023 (THOUSAND)
TABLE 173. NEW ZEALAND IVF MARKET, BY CYCLE TYPE, 2016-2023 ($MILLION)
TABLE 174. NEW ZEALAND IVF MARKET, BY CYCLE TYPE, 2016-2023 (THOUSAND)
TABLE 175. KOREA IVF MARKET, VOLUME AND VALUE, 2016-2023 (THOUSAND AND $MILLION)
TABLE 176. KOREA IVF MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 177. KOREA IVF MARKET, BY END USERS, 2016-2023 (THOUSAND)
TABLE 178. KOREA IVF MARKET BY CYCLE TYPE, 2016-2023 ($MILLION)
TABLE 179. KOREA IVF MARKET BY CYCLE TYPE, 2016-2023 (THOUSAND)
TABLE 180. THAILAND IVF MARKET, VOLUME AND VALUE, 2016-2023 (THOUSAND AND $MILLION)
TABLE 181. THAILAND IVF MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 182. THAILAND IVF MARKET, BY END USERS, 2015-2023 (THOUSAND)
TABLE 183. THAILAND IVF MARKET, BY CYCLE TYPE, 2016-2023 ($MILLION)
TABLE 184. THAILAND IVF MARKET BY CYCLE TYPE, 2016-2023 (THOUSAND)
TABLE 185. OTHER ASIA-PACIFIC IVF MARKET, VOLUME AND VALUE, 2016-2023 (THOUSAND AND $MILLION)
TABLE 186. OTHER ASIA-PACIFIC IVF MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 187. OTHER ASIA-PACIFIC IVF MARKET, BY END USERS, 2016-2023 (THOUSAND)
TABLE 188. OTHER ASIA-PACIFIC IVF MARKET BY CYCLE TYPE, 2016-2023 ($MILLION)
TABLE 189. OTHER ASIA-PACIFIC IVF MARKET BY CYCLE TYPE, 2016-2023 (THOUSAND)
TABLE 190. LAMEA IVF MARKET, BY COUNTRY, 2016 - 2023 (THOUSAND)
TABLE 191. LAMEA IVF MARKET, BY COUNTRY, 2016 - 2023 ($MILLION)
TABLE 192. LATIN AMERICA IVF MARKET, VOLUME AND VALUE, 2016-2023 (THOUSAND AND $MILLION)
TABLE 193. LATIN AMERICA IVF MARKET, BY END USERS, 2016-2023 (THOUSAND)
TABLE 194. LATIN AMERICA IVF MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 195. LATIN AMERICA IVF MARKET, BY CYCLE TYPE, 2016-2023 ($MILLION)
TABLE 196. LATIN AMERICA IVF MARKET, BY CYCLE TYPE, 2016-2023 (THOUSAND)
TABLE 197. CLINICA ANGLO AMERICANA BUSINESS OVERVIEW
TABLE 198. SNAPSHOT OF CLINICA ANGLO AMERICANA
TABLE 199. IVF PANAMA CENTRO DE REPRODUCCION PUNTA PACIFICA BUSINESS OVERVIEW
TABLE 200. SNAPSHOT OF IVF PANAMA CENTRO DE REPRODUCCION PUNTA PACIFICA
TABLE 201. INSAMER BUSINESS OVERVIEW
TABLE 202. COMPANY SNAPSHOT
TABLE 203. ALMATER HOSPITAL BUSINESS OVERVIEW
TABLE 204. COMPANY SNAPSHOT
TABLE 205. SAN FERNANDO HOSPITAL BUSINESS OVERVIEW
TABLE 206. COMPANY SNAPSHOT
TABLE 207. MIDDLE EAST IVF MARKET, VOLUME AND VALUE, 2016-2023 (THOUSAND AND $MILLION)
TABLE 208. MIDDLE EAST IVF MARKET, BY END USERS, 2016-2023 (THOUSAND)
TABLE 209. MIDDLE EAST IVF MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 210. MIDDLE EAST IVF MARKET, BY CYCLE TYPE, 2016-2023 ($MILLION)
TABLE 211. MIDDLE EAST IVF MARKET BY CYCLE TYPE, 2016-2023 (THOUSAND)
TABLE 212. CYPRUS IVF CENTRE BUSINESS OVERVIEW
TABLE 213. COMPANY SNAPSHOT
TABLE 214. AL BUSHRA MEDICAL SPECIALTY COMPLEX BUSINESS OVERVIEW
TABLE 215. COMPANY OF AL BUSHRA MEDICAL SPECIALTY COMPLEX
TABLE 216. REPRODUCTIVE MEDICINE UNIT AT CORNICHE HOSPITAL BUSINESS OVERVIEW
TABLE 217. SNAPSHOT OF REPRODUCTIVE MEDICINE UNIT AT CORNICHE HOSPITAL
TABLE 218. TRAKYA UNIVERSITY HOSPITAL ART CENTER BUSINESS OVERVIEW
TABLE 219. SNAPSHOT OF TRAKYA UNIVERSITY HOSPITAL ART CENTER
TABLE 220. AFRICA IVF MARKET, VOLUME AND VALUE, 2016-2023 (THOUSAND AND $MILLION)
TABLE 221. AFRICA IVF MARKET, BY END USERS, 2016-2023 (THOUSAND)
TABLE 222. AFRICA IVF MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 223. AFRICA IVF MARKET BY CYCLE TYPE, 2016-2023 ($MILLION)
TABLE 224. AFRICA IVF MARKET BY CYCLE TYPE, 2016-2023 (THOUSAND)
TABLE 225. LIFESURE FERTILITY & GYNAECOLOGY CENTRE BUSINESS OVERVIEW
TABLE 226. COMPANY SNAPSHOT
TABLE 227. BETHANY WOMEN AND FAMILY HOSPITAL BUSINESS OVERVIEW
TABLE 228. COMPANY SNAPSHOT
TABLE 229. BIOART FERTILITY CENTRE BUSINESS OVERVIEW
TABLE 230. COMPANY SNAPSHOT
TABLE 231. DEL INTERNATIONAL HOSPITAL & FERTILITY CENTRE BUSINESS OVERVIEW
TABLE 232. COMPANY SNAPSHOT
TABLE 233. GIFT OV LIFE BUSINESS OVERVIEW
TABLE 234. COMPANY SNAPSHOT
TABLE 235. DURBAN FERTILITY CLINIC BUSINESS OVERVIEW
TABLE 236. COMPANY SNAPSHOT
TABLE 237. CAPE FERTILITY CLINIC BUSINESS OVERVIEW
TABLE 238. COMPANY SNAPSHOT

LIST OF FIGURES

FIGURE 1. GLOBAL IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 2. GLOBAL IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 3. GLOBAL IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 4. GLOBAL IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 5. GLOBAL IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 6. GLOBAL IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 7. GLOBAL IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 8. GLOBAL IVF MARKET, BY GEOGRAPHY, 2016 AND 2023 ($MILLION)
FIGURE 9. GLOBAL IVF MARKET BY GEOGRAPHY, 2016 AND 2023 (THOUSAND)
FIGURE 10. UNITED STATES IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 11. UNITED STATES IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 12. UNITED STATES IVF MARKET, BY SURGICAL CENTERS, 2016-2023, VOLUME AND VALUE, (THOUSAND, $MILLION)
FIGURE 13. UNITED STATES IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 14. UNITED STATES IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 15. UNITED STATES IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 16. UNITED STATES IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 17. ART REGULATORY SCENARIO, UNITED STATES
FIGURE 18. CANADA IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 19. CANADA IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 20. CANADA IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 21. CANADA IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 22. CANADA IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 23. CANADA IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 24. CANADA IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 25. ART REGULATORY SCENARIO, CANADA
FIGURE 26. MEXICO IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 27. MEXICO IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 28. MEXICO IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 29. MEXICO IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 30. MEXICO IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 31. MEXICO IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 32. MEXICO IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 33. ART REGULATORY SCENARIO, MEXICO
FIGURE 34. GERMANY IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 35. GERMANY IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 36. GERMANY IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 37. GERMANY IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 38. GERMANY IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 39. GERMANY IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 40. REGULATORY SCENARIO, GERMANY
FIGURE 41. FRANCE IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 42. FRANCE IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 43. FRANCE IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 44. FRANCE IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 45. FRANCE IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 46. FRANCE IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 47. FRANCE IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 48. REGULATORY SCENARIO, FRANCE
FIGURE 49. UNITED KINGDOM IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 50. UNITED KINGDOM IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 51. UNITED KINGDOM IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 52. UNITED KINGDOM IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 53. UNITED KINGDOM IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 54. UNITED KINGDOM IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 55. UNITED KINGDOM IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 56. REGULATORY SCENARIO, UNITED KINGDOM
FIGURE 57. ITALY IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 58. ITALY IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 59. ITALY IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 60. ITALY IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 61. ITALY IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 62. ITALY IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 63. SPAIN IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 64. SPAIN IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 65. SPAIN IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 66. SPAIN IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 67. SPAIN IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 68. SPAIN IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 69. SPAIN IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 70. DENMARK IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 71. DENMARK IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 72. DENMARK IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 73. DENMARK IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 74. DENMARK IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 75. DENMARK IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 76. DENMARK IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 77. RUSSIA IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 78. RUSSIA IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 79. RUSSIA IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 80. RUSSIA IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 81. RUSSIA IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 82. RUSSIA IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 83. RUSSIA IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 84. OTHER EUROPE IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 85. OTHER EUROPE IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 86. OTHER EUROPE IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 87. OTHER EUROPE IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 88. REST OF EUROPE IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 89. REST OF EUROPE IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 90. REST OF EUROPE IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 91. INDIA TOTAL FERTILITY RATE (CHILDREN BORN/ WOMEN)
FIGURE 92. INDIA IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 93. INDIA IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 94. INDIA IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 95. INDIA IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 96. INDIA IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 97. INDIA IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 98. INDIA IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 99. CHINA FERTILITY RATE (CHILDREN BORN/WOMEN)
FIGURE 100. CHINA IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 101. CHINA IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 102. CHINA IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 103. CHINA IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 104. CHINA IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 105. CHINA IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 106. CHINA IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 107. JAPAN TOTAL FERTILITY RATE (CHILDREN BORN/ WOMEN)
FIGURE 108. JAPAN IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 109. JAPAN IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 110. JAPAN IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 111. JAPAN IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 112. JAPAN IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 113. JAPAN IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 114. AUSTRALIA TOTAL FERTILITY RATE ( CHILDREN BORN/ WOMEN)
FIGURE 115. IVF SUCCESS RATE FOR AUSTRALIA
FIGURE 116. AUSTRALIA IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 117. AUSTRALIA IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 118. AUSTRALIA IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 119. AUSTRALIA IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 120. AUSTRALIA IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 121. AUSTRALIA IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 122. NEW ZEALAND TOTAL FERTILITY RATE ( CHILDREN BORN/ WOMEN)
FIGURE 123. NEW ZEALAND IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 124. NEW ZEALAND IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 125. NEW ZEALAND IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 126. NEW ZEALAND IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 127. NEW ZEALAND IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 128. NEW ZEALAND IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 129. NEW ZEALAND IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 130. KOREA TOTAL FERTILITY RATE (CHILDREN BORN/WOMEN)
FIGURE 131. KOREA IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 132. KOREA IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 133. KOREA IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 134. KOREA IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 135. KOREA IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 136. KOREA IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 137. KOREA IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 138. THAILAND IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 139. THAILAND IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 140. THAILAND IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 141. THAILAND IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 142. THAILAND IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 143. THAILAND IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 144. OTHER ASIA-PACIFIC IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 145. OTHER ASIA-PACIFIC IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 146. OTHER ASIA-PACIFIC IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 147. OTHER ASIA-PACIFIC IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 148. OTHER ASIA-PACIFIC IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 149. OTHER ASIA-PACIFIC IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 150. OTHER ASIA-PACIFIC IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 151. LATIN AMERICA IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 152. LATIN AMERICA IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 153. LATIN AMERICA IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 154. LATIN AMERICA IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 155. LATIN AMERICA IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 156. LATIN AMERICA IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 157. LATIN AMERICA IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 158. ART REGULATORY SCENARIO, LATIN AMERICA
FIGURE 159. MIDDLE EAST IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 160. MIDDLE EAST IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 161. MIDDLE EAST IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 162. MIDDLE EAST IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 163. MIDDLE EAST IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 164. MIDDLE EAST IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 165. MIDDLE EAST IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 166. ART REGULATORY SCENARIO, MIDDLE EAST
FIGURE 167. AFRICA IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 168. AFRICA IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 169. AFRICA IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 170. AFRICA IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 171. AFRICA IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 172. AFRICA IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 173. AFRICA IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2016-2023, (THOUSAND, $MILLION)
FIGURE 174. ART REGULATORY SCENARIO, AFRICA

 

IVF procedure takes about four to six weeks for one cycle to be completed. It is because a series of process are involved in this procedure. The procedure starts with the ovary stimulation followed by follicle development, eggs retrieval, fertilization, embryos development & selection and finally implantation. The embryo selection is an important stage for the couples with high risk of passing on genetic disorder to their child. A test called pre-implantation genetic diagnosis (PGD) in which a single cell from each embryo is removed and screened for specific genetic disorders. It is done after 3-4 days of fertilization and help parents to decide on which embryos to implant.

The causes of infertility include advanced maternal age, ovulation disorder, damaged or blocked fallopian tube, premature ovarian failure, uterine fibroids, endometriosis, impaired sperm production or function, unexplained infertility. Although IVF has helped women to become pregnant, the success rate of it is depended on each couple's reasons for infertility and their ages and is associated with high risks. For example, women under 35 years of age have healthier eggs which favors the success of IVF procedure.

U.S. was the leading country market in IVF services market in 2016. Uniformity in regulatory and reimbursement policies could be the key driver of the market growth. Moreover, growing trends toward late conception along with decrease in birth rates has foreseen some initiatives from the government through fertility programs (such as U.S. Family Planning Program, The ARC Fertility Program, The Assisted Reproduction Insurance Program) by 2021.

The improved techniques have proved to be boon in IVF technology has given a chance to couples coping with fertility issues to have a complete family. New treatment options and technological developments, such as pre-implantation genetic diagnosis (PGD) and three-parent IVF procedures would potentially enhance the number of fertile eggs in women in the older age groups and could diminish the chances of genetic disorders in the resultant embryo. This would benefit them to avoid the costs associated with acquiring eggs, while resulting in an offspring of close genetic resemblance. Advances in assisted reproduction technologies, such as oocyte preservation and embryonic genetic testing to understand mechanisms involved in embryo development is crucial for improving the IVF success rates.

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry

Request sample

OR

Purchase Full Report of
In Vitro Fertilization (IVF) Services Market- Global Opportunity Analysis and Industry Forecast, 2017-2023

  • Online Only
  • $4176
  • Online cloud Access only
  • Restected Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $4640
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5540
  • Restricted to one authorized users
  • One print only
  • Available in PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6654
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprice
    License/PDF

  • $9280
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in PDF
  • 20% free customization (Pre-Sale)
  • Free quartery industry update
  • Free report update (Within 180 days)
  • Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo